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In our continuing program to isolate new compounds from the Madagascar sponge Biemna laboutei, 
five new tricyclic guanidine alkaloids, netamines O –  S (1 – 5, resp.),  have been identified together with 
the known compounds netamine E (6) and mirabilin J (7).  The structures of all new netamines were 
assigned on the basis of spectroscopic analyses. Their relative configurations were established by analysis 
of ROESY data and comparison with literature data. Netamines O, P, and Q, which were isolated in 
sufficient quantities, were tested for their cytotoxic activities against KB cells and their activities against 
the malaria parasite Plasmodium falciparum. Netamines O and Qwere found to bemoderately cytotoxic. 
Netamines O, P, and Q exhibited antiplasmodial activities with IC50 values of 16.99  4.12, 32.62  3.44, 
and 8.37  1.35  mm, respectively.
Introduction. – Tricyclic guanidine compounds, bearing a tricyclic 2-amino-1,3-
diazaoctahydroacenaphtylene skeleton, like ptilocaulins, mirabilins, and netamines, are
restricted to marine sponges of the order Poecilosclerida [1–11] and can be grouped on
the basis of their degree of oxidation and C¼C bond position with pyrimidine, D7,8-,
D8,8a-, D8a,8b-unsaturated, or saturated heterocycles. Many of these alkaloids were
reported to possess noteworthy biological activities, i.e., cytotoxic [1] [4] [8] [9] [12],
antibacterial [1] [7], antifungal [3], antimalarial [3] [11], and antiprotozoal activities
[3].
In 2006, we reported the isolation and structure elucidation of seven alkaloids,
named netamines A–G, from the Madagascar sponge Biemna laboutei Hooper, 1996
collected twice in May 2004 near Sainte Marie Island, and once in January 2005 at
Itampule [9]. From yet another collection of the sponge in October 2009 in Salary Bay
(ca. 100 km north of Tulear), we isolated several additional tricyclic guanidine
alkaloids, including the known netamine G, mirabilins A, C, and F, and seven new
tricyclic alkaloids, netamines H–N [11]. All the latter new compounds isolated from B.
laboutei possess a 5,6,8b-triazaperhydroacenaphtylene skeleton. Except for netamines
A–D that possess a saturated ring system, netamine E shows a C(8a)¼C(8b) bond,
netamines K–N have a C(8)¼C(8a) bond, and netamines F–J contain a pyrimidine
ring system.
In this article, we describe the isolation, structure elucidation, and biological
characterization of a series of five new tricyclic guanidines, netamines O–S (1–5),
along with the known compounds netamine E and mirabilin J. All these compounds,
isolated from the 2009 Salary Bay sponge, show a C(8a)¼C(8b) bond.
Results and Discussion. – Structure Elucidation. Chemical fractionation of the
crude extract, using a sequence of medium pressure liquid chromatography over silica
gel or reversed phase, followed by repetitive reversed-phase preparative HPLC,
yielded new (1–5) and known (6 and 7) compounds. The known compounds, netamine
E (6) and mirabilin J (7) were identified by comparison with published spectroscopic
data [8] [9] revised by Snider [10]. For the known isolated compound netamine E (6),
the [a]25D value of þ37.0 ([a]25D ¼ þ35.0 [9]) establishes the absolute configuration as
shown in the Figure. Although the optical rotations of all co-isolated compounds have
the same algebraic sign as netamine E, we were careful not to conclude for compounds
1–5 and favored to stick to our ROESY data and the relative configuration.
Netamine O (1) was obtained as pale yellow oil. The molecular formula was
established by HR-ESI-MS to be C17H28N3 . Analysis of the 1D and 2D 1H-, 13C-, and
15N-NMR data for 1 (Table 1) revealed resonances and correlations consistent with
those of a tricyclic guanidinium system with five C¼C bond equivalents, three CH2
(d(C) 30.9, 34.1, and 34.2) and four CH groups (34.8, 38.8, 39.9, and 53.0), a tetra-
Figure. Structures of the tricyclic guanidine alkaloids netamines O–S (1–5, resp.) , netamine E (6), and
mirabilin J (7). Relative configurations were determined by 1H,1H-ROESY (H$H) correlations.
substituted C¼C bond (120.6 and 129.4), a guanidine-like C-atom (154.3), and three N-
atoms (d(N) 78.1, 89.1, and 103.4). The HMB correlations of H¢C(5a) and CH2(1’)
with C(8a) (d(C) 129.4) and of H¢C(3a), CH2(4), CH2(5), and H¢C(5a) with C(8b)
(120.6) indicated a D8a,8b-unsaturated tricyclic ring system like in netamine E [9]. In
addition, HMBC data clearly indicated that the heterocyclic ring system is substituted
at C(7) (d(C) 34.8) and C(8) (39.9) by two alkyl groups summing up a total of seven C-
atoms. One substituent is a (2Z)-hex-2-en-1-yl group identified by a C(1’) to C(6’)
correlation sequence. Its linkage to the C(8)-atom was determined by the HMB
correlation of CH2(1’) with C(8). The geometry of the C¼C bond was confirmed by a
NOE correlation between CH2(1’) (d(H) 2.26–2.30) and CH2(4’) (1.96–2.01).
Therefore, the second substituent has to be a Me group (d(H) 1.07) attached to C(7)
on the basis of the COSY correlation of Me(1’’) with H¢C(7). Moreover, the relative
configuration of the four stereogenic centers at C(3a), C(5a), C(7), and C(8) was
determined by ROESY correlations betweenH¢C(3a) (d(H) 4.23–4.28) andH¢C(5a)
(2.46–2.52), H¢C(5a) andH¢C(7) (1.98–2.05), andH¢C(7) andH¢C(8) (2.31–2.35).
Thus, the four H-atoms were deduced to be at the same side of the tricyclic ring system
and the two side chains were established to be cis to each other. Therefore, the relative
configuration of Netamine O (1) is as shown in the Figure.
Netamine P (2) was isolated as white amorphous solid and has a molecular formula
of C19H32N3 , which was suggested by HR-ESI-MS. Analysis of the NMR data (Tables 2
and 3) indicated again a guanidinium moiety, i.e., the presence of three CH2 (d(C) 30.3,
Table 1. 1H- and 13C-NMR Data (500 and 125 MHz, resp.; in CD3OD) for Netamine O (1) . d in ppm,
J in Hz.
Position d(H) d(C) COSY HMBC (H!C)
1 12.10a) – – –
2 – 154.3 – –
H2N¢C(2) 6.49a) – – –
3 9.85a) – – –
3a 4.23–4.28 (m) 53.0 – 5, 8b
4 2.23–2.25 (m) 34.1 5 8b
5 1.18–1.21 (m), 1.70–1.76 (m) 34.2 4, 5a 3a, 8b
5a 2.46–2.52 (m) 38.8 5, 6 5, 8a, 8b
6 1.21–1.23 (m) 30.9 5a, 7 –
7 1.98–2.05 (m) 34.8 1’’, 6 1’, 1’’
8 2.31–2.35 (m) 39.9 – 1’, 1’’
8a – 129.4 – –
8b – 120.6 – –
1’ 2.26–2.30 (m) 26.9 8 2’, 8, 8a
2’ 5.34–5.41 (m) 129.1 3’ 3’
3’ 5.37–5.43 (m) 131.8 2’, 4’ 4’, 5’
4’ 1.96–2.01 (m) 30.7 3’, 5’ 3’, 6’
5’ 1.34–1.41 (m) 23.9 4’, 6’ 3’, 6’
6’ 0.92 (t, J¼7.1) 14.3 5’ 4’, 5’
1’’ 1.07 (d, J¼7.0) 19.4 7 7, 8
a) Recorded in DMF.
34.0, and 36.3) and four CH groups (37.6, 38.9, 42.2, and 54.2), a tetrasubstituted C¼C
bond (120.0 and 128.6), a deshielded sp2-hybridized C-atom (159.7), and three N-atoms
(d(N) 78.1, 89.1, and 102.2). Relevant correlations between the 1H- and 13C-NMR
spectra for netamines O and P (1 and 2 ; resp.) supported a tricyclic guanidine-like
arrangement with a C(8a)¼C(8b) bond. However, the differences observed between 1
and 2 in the 1H- and 13C-NMR spectra indicated that the Me group at C(7) of 1 is
replaced by a Pr group at C(7) in 2. The latter group was established by COSY
correlations observed between Me(3’’) (d(H) 0.94), CH2(2’’) (1.24–1.32 and 1.48–
1.52), CH2(1’’) (1.16–1.23 and 1.60–1.63), and H¢C(7) (1.52–1.56). NOESY
correlations between H¢C(5a) and H¢C(3a) and H¢C(7) determined all three
to be positioned at the same side of the molecule. In addition, NOESY correlations
recorded in (D7)DMF suggested that H¢C(3a) (d(H) 4.26–4.30), H¢C(5a) (2.36–
2.42), and H¢C(7) (1.52–1.56) are located at the same side, while H¢C(8) (1.97–2.00)
is located at the opposite side of the molecule. Thus, the side chains of 2 are trans to
each other.
Netamine Q (3) was obtained as white amorphous solid. The MS spectrum
suggested the same formula C19H32N3 as for 2, implying an isomeric structure.
Comparison of their 1D- and 2D-NMR data, reinforced by a detailed analysis of the
2D-NMR spectra, also revealed that the two molecules have the same constitution and
Table 2. 1H-NMR Data (in CD3OD) of Netamines O– S (1 – 5, resp.) . d in ppm, J in Hz.
Position 1a) 2a) 3b) 4a) 5a)
3a 4.23–4.28 (m) 4.26–4.30 (m) 4.23–4.26 (m) 4.25–4.28 (m) 4.25–4.30 (m)
4 2.23–2.25 (m) 1.65–1.69 (m),
2.16–2.23 (m)
1.70–1.76 (m),
2.22–2.25 (m)
1.65–1.72 (m),
2.16–2.24 (m)
1.63–1.69 (m),
2.16–2.23 (m)
5 1.18–1.21 (m),
1.70–1.76 (m)
1.28–1.34 (m),
1.96–2.02 (m)
1.20–1.23 (m) 1.22–1.29 (m),
1.98–2.03 (m)
1.97–2.03 (m)
5a 2.46–2.52 (m) 2.36–2.42 (m) 2.44–2.50 (m) 2.32–2.38 (m) 2.37–2.45 (m)
6 1.21–1.23 (m) 2.09–2.13 (m),
0.73–0.80 (m)
1.17–1.19 (m),
1.78–1.83 (m)
0.74–0.79 (m),
2.06–2.12 (m)
0.73–0.80 (m),
2.09–2.14 (m)
7 1.98–2.05 (m) 1.52–1.56 (m) 1.83–1.88 (m) 1.53–1.59 (m) 1.54–1.60 (m)
8 2.31–2.35 (m) 1.97–2.00 (m) 2.38–2.41 (m) 1.93–1.99 (m) 1.92–1.97 (m)
1’ 2.26–2.30 (m) 2.30–2.36 (m),
2.52–2.58 (m)
2.24–2.27 (m) 1.71–1.78 (m) 1.57–1.65 (m),
1.70–1.73 (m)
2’ 5.34–5.41 (m) 5.27–5.33 (m) 5.36–5.41 (m) 0.81 (t, J¼7.6) 1.15–1.20 (m),
1.25–1.27 (m)
3’ 5.37–5.43 (m) 5.48–5.54 (m) 5.37–5.43 (m) – 1.27–1.34 (m)
4’ 1.96–2.01 (m) 2.04–2.08 (m) 1.98–2.02 (m) – 1.27–1.34 (m)
5’ 1.34–1.41 (m) 1.36–1.44 (m) 1.34–1.41 (m) – 1.27–1.34 (m)
6’ 0.92 (t, J¼7.1) 0.93 (t, J¼7.1) 0.91 (t, J¼7.3) – 0.90 (t, J¼6.9)
1’’ 1.07 (d, J¼7.0) 1.16–1.23 (m),
1.60–1.63 (m)
1.30–1.32 (m),
1.42–1.47 (m)
1.14–1.22 (m) 1.17–1.22 (m)
2’’ – 1.24–1.32 (m),
1.48–1.52 (m)
1.40–1.42 (m) 1.27–1.35 (m) 1.27–1.34 (m),
1.46–1.53 (m)
3’’ – 0.94 (t, J¼7.0) 0.95 (t, J¼6.9) 0.94 (t, J¼7.1) 0.94 (t, J¼7.1)
a) Recorded at 500 MHz. b) Recorded at 600 MHz.
therefore different relative configurations. A NOESY experiment on 3 recorded in
(D7)DMF revealed that H¢C(3a) (d(H) 4.23–4.26) and H¢C(5a) (2.44–2.50) are
located at the same side, whereas H¢C(7) (1.83–1.88) and H¢C(8) (2.38–2.41)
appeared to be located at the opposite side of the molecule. The two side chains were
therefore established to be cis, as in netamine O (1), but at the opposite side of the
molecule compared to 1. Additionally, as in netamines O (1) and P (2), the geometry of
the C(2’)¼C(3’) bond was assigned to be cis on the basis of the NOESY correlation
between CH2(1’) and CH2(4’).
Netamine R (4) was isolated as pale yellow oil and showed the molecular
composition of C15H26N3 , consistent with an ammonium salt with five C¼C bond
equivalents. Analysis of the 1D and 2D 1H-, 13C-, and 15N-NMR data for 4 revealed
resonances and correlations consistent with those of a tricyclic guanidine with a
C(8a)¼C(8b) bond. The HMB correlations for 4 clearly indicated that the heterocyclic
ring system is substituted at C(7) (d(C) 37.7) and C(8) (42.9) by a Pr and an Et group,
resp. The position of the Pr group at C(7) was confirmed by COSY correlations
between CH2(1’’) and H¢C(7), and HMB correlations of Me(3’’) with C(2’’) and C(1’’).
Likewise, the location of the Et group at C(8) was confirmed by the COSY correlations
Me(2’)/CH2(1’) and CH2(1’)/H¢C(8). The absence of NOE correlations prevented the
determination of the configuration of 4. The latter was deduced from empirical
comparison of the chemical shifts of H¢C(3a), H¢C(5a), H¢C(7), and H¢C(8)
belonging to 4 with those of 1–3 and 6. Tables 2 and 3, set up for the purpose, showed
that chemical shifts of the four CH H-atoms of netamine R were close to those of
netamine P (2). The chemical shifts were also close to those of netamine E (6) [9] [10].
Table 3. 13C-NMR Data (in CD3OD) of Netamines O– S (1 – 5, resp.) . d in ppm.
Position 1a) 2a) 3b) 4a) 5a)
2 154.3 159.7 154.4 154.8 154.7
3a 53.0 54.2 53.0 54.0 54.1
4 34.1 34.0 34.1 34.1 34.0
5 34.2 30.3 31.1 30.4 30.4
5a 38.8 37.6 38.9 37.6 37.7
6 30.9 36.3 32.5 36.5 36.6
7 34.8 38.9 38.4 37.7 38.4
8 39.9 42.2 40.2 42.9 42.3
8a 129.4 128.6 129.5 128.4 128.8
8b 120.6 120.0 120.7 120.0 119.7
1’ 26.9 27.2 27.1 21.3 29.1
2’ 129.1 125.9 129.0 8.5 25.2
3’ 131.8 133.7 131.8 – 31.1
4’ 30.7 30.9 30.7 – 33.1
5’ 23.9 24.0 24.0 – 23.8
6’ 14.3 14.3 14.3 – 14.5
1’’ 19.4 37.4 36.6 37.4 37.4
2’’ – 21.6 21.8 21.4 21.4
3’’ – 14.9 14.7 14.8 14.8
a) Recorded at 125 MHz. b) Recorded at 150 MHz.
Thus, it was finally assumed that, as for 2 and 6, H¢C(3a), H¢C(5a), and H¢C(7) are at
the same side and H¢C(8) is located at the opposite side of the molecule in 4. The two
side chains are therefore trans-oriented.
Netamine S (5) was isolated as brown oil. The molecular formula C19H34N3 was
deduced from the HR-ESI-MS and spectroscopic data. Netamine S (5), with two
additional H-atoms compared to netamine P (2), was found to be the 2’,3’-dihydro
analog of 2. The NOESY correlations H¢C(3a) (d(H) 4.25–4.30)/H¢C(5a) (2.37–
2.45) and H¢C(5a)/H¢C(7) (1.54–1.60) confirmed the location at the same side of the
molecule for these three H-atoms. No correlation was observed between these three H-
atoms and H¢C(8) (d(H) 1.92–1.97), excluding placement of H¢C(8) at the same side
of the molecule.
Biological Studies. The crude extract of the B. laboutei sponge showed potent
cytotoxic activity against the KB tumor cell line (96.9% inhibition at 10 mm
concentration). Netamines O–Q isolated in sufficient quantities were therefore
evaluated for their cytotoxic activities against KB cells. Netamines O and Q were
cytotoxic in the range of 10¢5 m. Among the known guanidine compounds bearing a
tricyclic 5,6,8b-triazaperhydroacenaphtylene skeleton, cytotoxic activities against
cancer cell lines were also observed for ptilocaulin (D8,8a), isoptilocaulin (D6,7),
mirabilin C acetate (pyrimidine), mirabilins F, G, and I (D8,8a), mirabilins H and K
(D8a,8b), and netamines C and D (saturated) [1] [4] [8] [9]. The cytotoxic activity of a
synthetic racemic ptilocaulin was studied by Rubent et al. [12] in order to evaluate its in
vitro activities against various cell lines. Moreover, the authors have shown that
ptilocaulin was toxic at 50 and 25 mg kg¢1 in an in vivo L1210 tumor model and was
ineffective at lower concentrations (T/C 100–112%).
The crude extract of the B. laboutei sponge also displayed promising in vitro
antiplasmodial activity (IC50 3.260.25 mm). Thus, the in vitro activity of netamines
O–Q was undertaken against Plasmodium falciparum. All other compounds were not
isolated in sufficient quantities. Netamines O–Q exhibited antimalarial activities with
IC50 values of 16.994.12, 32.623.44, and 8.371.35 mm, respectively (Table 4). Four
other tricyclic alkaloids have been reported as being active against the malaria parasite
P. falciparum: a mixture of 1,8a-/8b,3a-dihydro-8b-hydroxyptilocaulin and 1,8a-/8b,3a-
dihydro-8a-hydroxyptilocaulin (prymidine) with an IC50 value of 3.8 mg ml¢1 [3],
netamine K, and mirabilin A with IC50 values of 2.4 and 20.7 mm, respectively.
Table 4. Antiplasmodial Activities of the Crude Extract of B. laboutei and of Netamines O–Q (1–3,
resp.) against P. falciparum
Crude extract and pure compounds IC50 [mm]a)
Crude extract 3.260.25
1 16.994.12
2 32.623.44
3 8.371.35
Artemisininb) 0.0140.004
Chloroquineb) 0.0500.034
a) The results were the average means of three replicate determinationsSD. b) Positive control.
Conclusions. – Five new tricyclic guanidine alkaloids, netamines O–S (1–5 ; resp.),
together with the known compounds netamine E (6) and mirabilin J (7), were isolated
from the sponge B. laboutei. Netamines O–Q, isolated in sufficient quantities, were
evaluated for their cytotoxic and antiplasmodial activities. Netamines O and Q
exhibited moderate cytotoxic activities. Netamines O–Q exhibited good antiplasmo-
dial activities.
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Experimental Part
General. All solvents were anal. or HPLC grade and were used without further purification. Thin
layer chromatography (TLC): precoated silica gel 60 F254 sheets (SiO2); visualized by UV light at 254 nm
and by spraying with vanillin/H2SO4 followed by heating. MPLC: Teledyne Isco CombiFlash Ô
Companion Ô with a RediSep prepacked normal-phase column (120 g) and Bîchi system, including
two C-605 pumps, a C-615 pump manager, a C-660 fraction collector, and a glass column (36 46 mm)
packed withMacherey¢NagelMNKieselgel (70–230 mm). Anal. HPLC:Kinetex (4.6 100 mm, 5 mm) or
Waters SunFire (4.6 150 mm, 5 mm) column;Waters 2695 Alliance system equipped with a photodiode
array detector (Waters 996), an evaporative light scattering detector (Waters 2420), and a mass
spectrometer (Waters Micromass ZQ 2000). Prep. HPLC:Waters SunFire Prep reversed-phase C18 (RP-
C18) column (19 150 mm, 5 mm); Waters 600 system controller equipped with a photodiode array
detector (Waters 2996). Optical rotations: MCP 300 Modular Circular Polarimeter Anton Paar at 258.
UV Spectra: Varian Cary spectrometer; in MeOH; lmax (log e) in nm. IR Spectra: PerkinElmer Spectrum
100 FT-IR spectrometer model instrument; dry film; n˜ in cm¢1. 1H- and 13C-NMR spectra: Bruker
UltraShield Avance-300, ¢500, and DRX-600 spectrometers; d in ppm rel. to solvent signals (d(H) 3.31
and d(C) 49.15 for CD3OD; d(H) 8.03 and d(C) 163.00 for (D7)DMF), J in Hz. The spectra were
processed using 1D- and 2D-NMR notebook software. NOESY or ROESY spectra were recorded in
(D7)DMF or CD3OD (see the Supporting Information1)). CDCl3 was used only for comparison with
known compounds. HR-ESI-MS: LCT Premier XE Micromass spectrometer; in m/z.
Animal Material. The sponge B. laboutei Hooper, 1996 (phylum, Porifera; class, Demospongiae;
order, Poecilosclerida; family, Desmacellidae), identified by J. V., was collected in October 2009 at four
sampling stations in Salary Bay, Madagascar: station 1 (22831’727’’ S, 43813’597’’ E, at 18 m depth),
station 2 (22830’952’’ S, 43812’558’’ E, at 25–30 m depth), station 3 (22831’988’’ S, 43813’036’’ E, at 30 m
depth), station 4 (22831’822’’ S, 43812’939’’ E, at 25–27 m depth). Seven voucher specimens (#
MHNM.16242.1, MHNM.16242.2, MHNM.16242.3, MHNM.16242.4, MHNM.16242.5, MHNM.16242.6,
and MHNM.16242.7) were deposited with the Museum dÏHistoire Naturelle de Marseille, Palais
Longchamp, 1 Bd Philippon, FR-13004 Marseille. Sponge samples were frozen immediately and kept at
¢208 until processing.
Extraction and Isolation. The CH2Cl2/MeOH 1 :1 (3 3.5 l, each 24 h) extract (87 g) was obtained by
maceration of the freeze-dried sponge (358 g) at r.t. The extract was then subjected to MPLC (SiO2 ;
isohexane/AcOEt/MeOH with increasing polarity) to give four fractions, Frs. 1–4. Fr. 1 was eluted with
isohexane/AcOEt 95 :5, Fr. 2 was eluted with isohexane/AcOEt 85 :15, Fr. 3 was eluted with AcOEt, and
Fr. 4 was eluted with AcOEt/MeOH 70 :30.
1) Supporting material is available upon request from the authors.
Separation of Fr. 4 (2.6 g) by MPLC (RP-C18 ; H2O/MeOH (þ0.1% HCOOH)) gave twelve
subfractions, Frs. 4.1–4.12. Anal. HPLC (Waters SunFire C18 (4.6 150 mm, 5 mm); 45%MeOH/H2O (þ
0.1% HCOOH) to 70% MeOH/H2O (þ0.1% HCOOH), 1 ml min¢1 gradient elution over 45 min; UV
254 nm, ELS) analyses showed that the isolated compounds are present in Frs. 4.5 (108.8 mg) and 4.10
(150.0 mg). Fr. 4.5was subjected to semi-prep. HPLC (Waters SunFire RP-C18 (19 150 mm, 5 mm); 55%
MeOH/H2O (þ0.1% HCOOH) to 68%MeOH/H2O (þ0.1% HCOOH), 4.8 ml min¢1 gradient elution
over 20 min; UV 254 nm) to furnish four subfractions, Frs. 4.5.1–4.5.4, containing pure compound 7
(mirabiline J; 5.5 mg). Fr. 4.10 was subjected to subsequent semi-prep. HPLC (Waters SunFire RP-C18 ;
75%MeOH/H2O (þ0.1%HCOOH), 5 ml min¢1 isocratic elution over 15 min; UV 254 nm) to give five
subfractions, Frs. 4.10.1–4.10.5. Two of them, Frs. 4.10.2 and 4.10.3, afforded pure compounds 6
(netamine E; 4.0 mg) and 3 (netamine Q; 8.9 mg).
Fr. 4 (360 mg) was also subjected to prep. HPLC (Waters SunFire Prep RP-C18 (19 150 mm, 5 mm);
45% MeOH/H2O (þ0.1% HCOOH) to 70% MeOH/H2O (þ0.1% HCOOH), 17 ml min¢1 gradient
elution over 45 min; UV 254 nm) to give 13 subfractions, Frs. 4.1’–4.13’. One of them afforded 1
(netamine O; 8.4 mg). Three other subfractions were subjected to subsequent prep. HPLC (Waters
SunFire Prep RP-C18 ; 55% MeOH/H2O (þ0.1% HCOOH) to 70% MeOH/H2O (þ0.1% HCOOH),
17 ml min¢1 gradient elution over 26 min; UV 254 nm) to give pure compounds 2 (netamine P; 3.9 mg), 4
(netamine R; 1.9 mg), and 5 (netamine S; 1.9 mg).
Netamine O (¼ (3aS*,5aS*,7R*,8R*)-8-[(2Z)-Hex-2-en-1-yl]-3,3a,4,5,5a,6,7,8-octahydro-7-methyl-
cyclopenta[de]quinazolin-2-amine ; 1). Yellow oil. [a]25D ¼ þ61.6 (c¼1.33, MeOH). UV: 234 (0.95), 302
(0.28). IR: 2990, 1599. 1H- and 13C-NMR: see Table 1. HR-ESI-MS: 274.2271 (Mþ , C17H28Nþ3 ; calc.
274.2278).
Netamine P (¼ (3aS*,5aS*,7R*,8S*)-8-[(2Z)-Hex-2-en-1-yl]-3,3a,4,5,5a,6,7,8-octahydro-7-propyl-
cyclopenta[de]quinazolin-2-amine ; 2). White solid. [a]25D ¼ þ219.0 (c¼1.46, MeOH). UV: 235 (0.56).
IR: 3290, 1646. 1H- and 13C-NMR: see Tables 2 and 3. HR-ESI-MS: 302.2600 (Mþ , C19H32Nþ3 ; calc.
302.2591).
Netamine Q (¼ (3aS*,5aS*,7S*,8S*)-8-[(2Z)-Hex-2-en-1-yl]-3,3a,4,5,5a,6,7,8-octahydro-7-propylcy-
clopenta[de]quinazolin-2-amine ; 3). Yellow oil. [a]25D ¼ þ18.3 (c¼0.30, MeOH). UV: 233 (0.94), 305
(0.17). IR: 3300, 1648. 1H- and 13C-NMR: see Tables 2 and 3. HR-ESI-MS: 302.2578 (Mþ , C19H32Nþ3 ;
calc. 302.2591).
Netamine R (¼ (3aS*,5aS*,7R*,8S*)-8-Ethyl-3,3a,4,5,5a,6,7,8-octahydro-7-propylcyclopenta[de]qui-
nazolin-2-amine; 4). Pale yellow oil. [a]25D ¼ þ18.0 (c¼0.10, MeOH). UV: 238 (0.63). IR: 3300, 1650. 1H-
and 13C-NMR: see Tables 2 and 3. HR-ESI-MS: 248.2146 (Mþ , C15H26Nþ3 ; calc. 248.2121).
Netamine S (¼ (3aS*,5aS*,7R*,8S*)-8-Hexyl-3,3a,4,5,5a,6,7,8-octahydro-7-propylcyclopenta[de]qui-
nazolin-2-amine; 5). Pale brown oil. [a]25D ¼ þ20.0 (c¼0.10, MeOH). UV: 248 (0.30). IR: 3300, 1650. 1H-
and 13C-NMR: see Tables 2 and 3. HR-ESI-MS: 304.2748 (Mþ , C19H34Nþ3 ; calc. 304.2747).
Netamine E (¼ (3aS,5aS,7R,8S)-8-Butyl-3,3a,4,5,5a,6,7,8-octahydro-7-propylcyclopenta[de]quinazo-
lin-2-amine; 6). Yellow oil. [a]25D ¼ þ37.0 (c¼0.10, CH2Cl2). UV: 238 (0.63). HR-ESI-MS: 276.2441 (Mþ ,
C17H30Nþ3 ; calc. 276.2434).
Mirabilin J (¼ (3aS,5aS,7R,8S)-2-Amino-8-[(2Z)-hex-2-en-1-yl]-3,3a,4,5,5a,6,7,8-octahydro-7-meth-
ylcyclopenta[de]quinazolin-8-ol; 7). Brown oil. [a]25D ¼ þ78.0 (c¼0.18, CH2Cl2). HR-ESI-MS: 290.2238
(Mþ , C17H28N3Oþ ; calc. 290.2227).
In vitro Cytotoxicity Assay Against KB Cell Line. Cell proliferation was measured with Celltiter 96
Aqueous One soln. reagent (Promega) and results are expressed as the percentage of inhibition of
cellular proliferation of KB cells treated for 72 h with 1–3 compared to cells treated with DMSO only
(mean SE of triplicate). The IC50 determinations were performed in duplicate experiments and are
expressed as individual values.
In vitro Antiplasmodial Assays. P. falciparum strains were utilized and details of the assay protocols
have been previously reported [13]. Artemisinin (98%; Sigma¢Aldrich) and chloroquine (> 98%;
Sigma¢Aldrich) were used as positive controls.
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